{
  "url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2004/schedule-7/part-1",
  "json_url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2004/schedule-7/part-1.json",
  "legislation": "uksi/2004/2152",
  "legislation_title": "The Cosmetic Products (Safety) Regulations 2004",
  "legislation_url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2004",
  "path": "schedule/7/part/1",
  "kind": "part",
  "number": "1",
  "heading": "UV FILTERS LISTED IN ANNEX VII, PART 1 OF THE DIRECTIVE AS UV FILTERS WHICH COSMETIC PRODUCTS MAY NOT CONTAIN EXCEPT SUBJECT TO THE RESTRICTIONS LAID DOWN",
  "text": "(1)\n(2)\n(3)\n(4)\n(5)\nReference Number\nName of substance\nMaximum concentration of substance in product\nOther requirements\nRequired information\n1\n4-Aminobenzoic acid [PABA]\n5 per cent\n—\n—\n2\nN,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl)anilinium methyl sulphate [Camphor benzalkonium methosulfate]\n6 per cent\n—\n—\n3\nHomosalate (INN)\n10 per cent\n—\n—\n4\nOxybenzone (INN)\n[Benzophenone-3]\n10 per cent\n—\nContains oxybenzone. (Not required when concentration is not more than 0.5 per cent, and when the substance is only intended to protect the product)\n5\nENTRY DELETED\n6\n2-Phenylbenzimidazole-5-sulphonic acid [Phenylbenzimidazole sulfonic acid] and its potassium, sodium and triethanolamine salts\n8 per cent (expressed as acid)\n—\n—\n7\n3,3-(1,4-Phenylenedimethylene)bis(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonic acid) [Terephthalylidene dicamphor sulfonic acid] and its salts\n10 per cent (expressed as acid)\n—\n—\n8\n1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dione (Avobenzone (INN))\n[Butyl methoxy dibenzoylmethane]\n5 per cent\n—\n—\n9\nα-(2-Oxoborn-3-ylidine)toluene-4-sulphonic acid [Benzylidene camphor sulfonic acid] and its salts\n6 per cent (expressed as acid)\n—\n—\n10\n2-Ethylhexyl 2-cyano-3,3-diphenylacrylate [Octocrylene]\n10 per cent (expressed as acid)\n—\n—\n11\nPolymer of N-[(2 and 4)-[2-oxoborn-3-ylidene)methyl]benzyl]acrylamide\nPolyacrylamidomethyl benzylidene camphor]\n6 per cent\n—\n—\n12\n2-Ethylhexyl 4-methoxycinnamate\n[Octyl methoxycinnamate]\n10 per cent\n—\n—\n13\nEthoxylated ethyl-4-aminobenzoate\n[PEG-25 PABA]\n10 per cent\n—\n—\n14\nIsopentyl 4-methoxycinnamate\n[Isoamyl p-methoxycinnamate]\n10 per cent\n—\n—\n15\nTris(2-ethylhexyl) 4,4’4”-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate\n[Octyl triazone]\n5 per cent\n—\n—\n16\n2-(2H-Benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-l-(trimethylsilyloxy)-disiloxan-1-yl]propyl]phenol\n[Drometrizole trisiloxane]\n15 per cent\n—\n—\n17\nBis(2-ethylhexyl) 4,4’-[6-tert-butylcarbamoylanilino)-1,3,5-triazine-2,4-diyldiimino]dibenzoate\n10 per cent\n—\n—\n18\n3-(4-Methylbenzylidine)bornan-2-one\n[4-Methylbenzylidene camphor]\n4 per cent\n—\n—\n19\n3-Benzylodenebornan-2-one\n[3-Benzylidene camphor\n2 per cent\n—\n—\n20\n2-Ethylhexyl salicylate\n[Octyl salicylate]\n5 per cent\n—\n—\n21\n2-Ethylhexyl 4-dimethylaminobenzoate\n[Octyl dimethyl PABA]\n8 per cent\n—\n—\n22\n2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid [Benzophenone-4] and its sodium salt [Benzophenone-5] (Sulisobenzone (INN) and Sulisobenzone sodium (INNM))\n5 per cent (expressed as acid)\n—\n—\n23\n2-2’-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol]\n10 per cent\n—\n—\n24\ndiSodium 2,2’-(1,4-phenylene)bis(lH-benzimidazole-4,6-disulfonate)\n10 per cent (expressed as acid)\n—\n—\n25\n5,5’-Bis(2-ethylhexyloxy)-2,2’-(6-p-methoxyphenyl-1,3,5-triazine-2, 4-diyl)diphenol\n10 per cent\n—\n—\n26\nα-(Trimethylsilyl)-w-(trimethylsilyloxy)poly-[oxy(dimethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl]phenoxy]-1-methyleneethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl)]phenoxy]prop-1-enyl)silylene] where there are usually 60 polymeric units, of which the first part of the copolymer provides 56 (Dimethicodiethylbenzyalmalonate)\n(CAS No. 207574-74-1)\n10 per cent\n—\n—\n27\nTitanium dioxide\n25 per cent\n—\n—",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 7 Pt. 1 in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)"
    },
    {
      "type": "I",
      "label": "I2",
      "text": "Sch. 7 Pt. 1 in force at 11.3.2005 in so far as commenced by inducing reg. 7(2)(9), see reg. 1(2)"
    }
  ],
  "outstanding_effects": [
    {
      "type": "word substituted",
      "affecting": "uksi/2004/2988",
      "affecting_title": "The Cosmetic Products (Safety) (Amendment) (No.2) Regulations 2004"
    },
    {
      "type": "word substituted",
      "affecting": "uksi/2004/2988",
      "affecting_title": "The Cosmetic Products (Safety) (Amendment) (No.2) Regulations 2004"
    },
    {
      "type": "coming into force",
      "affecting": "uksi/2004/2152",
      "affecting_title": "The Cosmetic Products (Safety) Regulations 2004"
    },
    {
      "type": "coming into force",
      "affecting": "uksi/2004/2152",
      "affecting_title": "The Cosmetic Products (Safety) Regulations 2004"
    },
    {
      "type": "am",
      "affecting": "uksi/2005/1815",
      "affecting_title": "The Cosmetic Products (Safety) (Amendment) Regulations 2005"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2004/2152/schedule/7/part/1",
    "retrieved_at": "2026-10-29T05:20:02.092817+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}